Thermostable vacuum foam dried Newcastle disease vaccine: Process optimization and pilot-scale study

  • Fang Lyu
  • , Yan Hong Zhao
  • , Xiao Xin Zuo
  • , Babalwa Nyide
  • , Bi Hua Deng
  • , Ming Xu Zhou
  • , Jibo Hou
  • , Jia Jie Jiao
  • , Min Qian Zeng
  • , Hong Ying Jie
  • , Ademola Olaniran
  • , Yu Lu
  • , Thandeka Khoza

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Abstract: Vacuum foam drying (VFD) has been shown to improve the thermostability and long-term shelf life of Newcastle Disease Virus (NDV). This study optimized the VFD process to improve the shelf life of NDV at laboratory-scale and then tested the optimized conditions at pilot-scale. The optimal NDV to T5 formulation ratio was determined to be 1:1 or 3:2. Using the 1:1 virus to formulation ratio, the optimal filling volumes were determined to be 13–17% of the vial capacity. The optimized VFD process conditions were determined to be at a shelf temperature of 25℃ with a minimum overall drying time of 44 h. The vaccine samples prepared using these optimized conditions at laboratory-scale exhibited virus titer losses of ≤ 1.0 log10 with residual moisture content (RMC) below 3%. Furthermore, these samples were transported for 97 days around China at ambient temperature without significant titer loss, thus demonstrating the thermostability of the NDV-VFD vaccine. Pilot-scale testing of the NDV-VFD vaccine at optimized conditions showed promising results for up-scaling the process as the RMC was below 3%. However, the virus titer loss was slightly above 1.0 log10 (approximately 1.1 log10). Therefore, the NDV-VFD process requires further optimization at pilot scale to obtain a titer loss of ≤ 1.0 log10. Results from this study provide important guidance for possible industrialization of NDV-VFD vaccine in the future. Key points: • The process optimization and scale-up test of thermostable NDV vaccine prepared through VFD is reported for the first time in this study. • The live attenuated NDV-VFD vaccine maintained thermostability for 97 days during long distance transportation in summer without cold chain conditions. • The optimized NDV-VFD vaccine preparations evaluated at pilot-scale maintained acceptable levels of infectivity after preservation at 37℃ for 90 days, which demonstrated the feasibility of the vaccine for industrialization.

Original languageEnglish
Article number359
JournalApplied Microbiology and Biotechnology
Volume108
Issue number1
DOIs
Publication statusPublished - Dec 2024
Externally publishedYes

Keywords

  • NDV vaccine
  • Process upscaling
  • Thermostability
  • Vacuum foam drying

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology

Fingerprint

Dive into the research topics of 'Thermostable vacuum foam dried Newcastle disease vaccine: Process optimization and pilot-scale study'. Together they form a unique fingerprint.

Cite this